Travere Therapeutics, Inc. (TVTX)
67.49
+0.37
(+0.55%)
USD |
NASDAQ |
Aug 27, 16:00
67.49
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics EPS Diluted (TTM) : -0.7636 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7636 |
| March 31, 2026 | -0.5348 |
| December 31, 2025 | -0.603 |
| September 30, 2025 | -1.085 |
| June 30, 2025 | -2.040 |
| March 31, 2025 | -2.805 |
| December 31, 2024 | -4.102 |
| September 30, 2024 | -4.557 |
| June 30, 2024 | -4.838 |
| March 31, 2024 | -5.056 |
| December 31, 2023 | -4.559 |
| September 30, 2023 | -4.404 |
| June 30, 2023 | -4.506 |
| March 31, 2023 | -4.432 |
| December 31, 2022 | -4.370 |
| September 30, 2022 | -4.182 |
| June 30, 2022 | -3.680 |
| March 31, 2022 | -3.271 |
| December 31, 2021 | -3.024 |
| September 30, 2021 | -4.56 |
| June 30, 2021 | -4.417 |
| March 31, 2021 | -4.355 |
| December 31, 2020 | -3.379 |
| September 30, 2020 | -1.710 |
| June 30, 2020 | -2.117 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.457 |
| December 31, 2019 | -3.465 |
| September 30, 2019 | -2.942 |
| June 30, 2019 | -3.432 |
| March 31, 2019 | -3.070 |
| December 31, 2018 | -2.544 |
| September 30, 2018 | -2.813 |
| June 30, 2018 | -1.933 |
| March 31, 2018 | -1.713 |
| December 31, 2017 | -1.57 |
| September 30, 2017 | -1.383 |
| June 30, 2017 | -1.923 |
| March 31, 2017 | -1.953 |
| December 31, 2016 | -1.713 |
| September 30, 2016 | -1.518 |
| June 30, 2016 | 1.262 |
| March 31, 2016 | 0.9019 |
| December 31, 2015 | 2.287 |
| September 30, 2015 | 1.255 |
| June 30, 2015 | -1.415 |
| March 31, 2015 | -1.585 |
| December 31, 2014 | -5.92 |
| September 30, 2014 | -5.52 |
| June 30, 2014 | -5.34 |
| March 31, 2014 | -4.85 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AbbVie, Inc. | 3.537 |
| Insmed, Inc. | -4.105 |
| United Therapeutics Corp. | 27.96 |
| Krystal Biotech, Inc. | 7.979 |
| Relay Therapeutics, Inc. | -1.567 |